PCI Biotech: Notice of Annual General Meeting 2017


Oslo, 8 May 2017

The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2017 at Oslo Cancer Cluster Innovation Park.

Time: Monday May 29, 10am CEST (local time).
Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway.

Please find attached Notice of Annual General Meeting including attendance and proxy forms, executive remuneration statement and the recommendation from the Nomination Committee.

The notice including attendance and proxy forms will be sent by mail to all shareholders with known address.

The complete notice is available at PCI Biotech's corporate website www.pcibiotech.com.

For further information, please contact:

Ronny Skuggedal, CFO
E-mail: rs@pcibiotech.no
Office: +47 67 11 54 00
Mobile: +47 94 00 57 57

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Pièces jointes

PCIB Notice of Annual General Meeting 2017 PCIB Proposal from the Nomination Committee PCIB Executive remuneration statement
GlobeNewswire